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Abstract
Background: Cellular senescence plays important roles in the aging process of complex organisms, in tumor
suppression and in response to stress. Several markers can be used to identify senescent cells, of which the most
widely used is the senescence-associated b-galactosidase (SABG) activity. The main advantage of SABG activity over
other markers is the simplicity of the detection assay and the capacity to identify in situ a senescent cell in a
heterogeneous cell population. Several approaches have been introduced to render the SABG assay quantitative.
However none of these approaches to date has proven particularly amenable to quantitative analysis of SABG
activity in situ. Furthermore the role of cellular senescence (CS) in vivo remains unclear mainly due to the
ambiguity of current cellular markers in identifying CS of individual cells in tissues.
Results: In the current study we applied a digital image analysis technique to the staining generated using the
original SABG assay, and demonstrate that this analysis is highly reproducible and sensitive to subtle differences in
staining intensities resulting from diverse cellular senescence pathways in culture. We have further validated our
method on mouse kidney samples with and without diabetes mellitus, and show that a more accurate quantitative
SABG activity with a wider range of values can be achieved at a pH lower than that used in the conventional
SABG assay.
Conclusions: We conclude that quantitative in situ SABG assay, is feasible and reproducible and that the pH at
which the reaction is performed should be tailored and chosen, depending on the research question and
experimental system of interest.
Background
Cellular senescence (CS) is a term used to describe the
process wherein somatic cells of complex eukaryotic
organisms progressively lose replicative capacity. The
relationship between CS and organismal aging is still
unclear although recent studies in non-human and
human primates have strongly implicated a correlation
between organismal and cellular aging [1,2]. Overall,
recent studies have suggested that CS is a final common
pathway resulting from activation of the cellular DNA
damage response (DDR) by various stressors that con-
verge on the p53 and/or pRB pathways. Different DDR
inducing stimuli can lead to various types of CS. Among
those most thoroughly investigated is the activation of
DDR by telomere attrition which leads to cell cycle
arrest termed replicative senescence (RS) or telomere-
initiated CS [3-5]. Other well studied forms of CS
include oncogene-induced senescence [6-8], cell struc-
ture induced senescence related to dysfunctional Lamin
A [9], and stress-induced premature senescence (SIPS),
the latter most thoroughly studied in relation to oxida-
tive stress [10-12]. These various triggers of CS might
not necessarily be mutually exclusive. Furthermore,
DDR might not be the exclusive mechanism for trigger-
ing CS as protein damage, epigenetic changes [13] and
additional processes have also been implicated [5,14]. In
complex long-lived organisms CS is considered to be a
tumor suppressor mechanism similar to apoptosis and
autophagy [15]. However, in contrast to apoptosis and
autophagy, which are irreversible and lead to cell death,
senescent cells maintain partial metabolic functionality
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capacity to revert back to a proliferative state [14].
Several markers of senescence have been described [5].
Among others these include G1 cell cycle arrest
detected by lack of DNA replication, cytological markers
such as senescence-associated heterochromatin foci
(SAHF), senescence-associated DNA-damage foci, as
well as cell structure changes such as cell size and lyso-
somal b-galactosidase activity detected at pH 6.0 defined
as senescence-associated b-galactosidase (SABG) activity
[16,17]. Since first reported, SABG activity has been the
most extensively utilized biomarker for CS both in in
situ [16,18-20] and in in vitro studies (reviewed in [17]).
I nm a n ys t u d i e st h ei d e n t i f i c a t i o no fc e l l sa sb e i n g
senescent rests solely on the SABG assay. The popular-
ity of this method can be attributed to its simplicity and
apparent specificity for CS regardless of the initiating
trigger, as well as the ability to visualize senescent cells
in a heterogeneous population [17].
Despite the extensive utilization of the SABG assay for
CS determination, the origin of SABG activity and its
role in CS were unknown for several years following its
initial description. A number of studies have proposed
that lysosomal b-galactosidase activity increases in
senescent cell up to a degree that surpasses a threshold
level that renders the activity detectable at a suboptimal
pH 6.0 [21,22]. A later study clearly demonstrated that
the SABG activity arises from the lysosomal b-galactosi-
dase 1 (GLB1) gene product [23]. In senescence cells,
both the mRNA and the protein levels of this gene are
significantly elevated, and the enzymatic activity
increases concomitantly [23]. Furthermore, the
enhanced enzymatic activity in senescence can be mea-
sured both at the optimal pH for activity - pH 4.5 as
well as at the suboptimal pH 6.0. These findings demon-
strate that the significantly increased SABG activity at
senescence is the basis for the activity detected at the
suboptimal pH 6.0, and therefore used as a marker for
senescence [23].
The extent of the senescence-induced increase in lysoso-
mal b-galactosidase can be measured by Western blotting
or soluble enzymatic activity [23], however the activity of
b-galactosidase is most easily and robustly detected by his-
tochemical staining with X-gal serving as a substrate [23].
In addition to age related accumulation of lysosomal b-
galactosidase in senescent cells probably due to the
increased lysosomal content in the cell, other yet unknown
factors such as functional differences in senescent lyso-
somes may contribute to the very high levels of b-galacto-
sidase observed by SABG staining at pH 6.0 [23].
Despite its ease and utility, concerns have arisen
regarding the specificity and reproducibility of the
SABG assay. Studies that question the specificity of the
SABG assay as a CS marker have found SABG activity
in quiescent cell cultures [24], confluent non-trans-
formed fibroblasts cultures [25,26] and in serum starved
cells [26]. Other concerns relate to the nature of the
semi-quantitative measure. Previously described scoring
has been based on experimentalist-dependent determi-
nation of a given cell as being positively or negatively
stained, and may not be anchored in reproducible cri-
teria. Furthermore, the intensity of blue staining in posi-
tive cells may be difficult to quantify, such that cells
with strong, moderate, or weak blue staining may all be
recognized as equally positive. This renders the method
insensitive to subtle effects of various stressors on CS,
and might contribute to the inconsistency in replicating
SABG assay results in skin biopsies [25].
The foregoing motivated us to develop a quantitative
in situ SABG assay, which could be more easily applic-
able and reproducible in the study of CS both in vitro
and in situ. We have utilized the framework of the
widely utilized protocol of the in situ SABG assay [16],
and applied digital-image processing in order to perform
quantification of the assay staining. In addition, we have
also varied the pH of the assay to broaden the range of
histochemically detectable activity. We show validation
of this quantitative in situ SABG assay on cultured
human foreskin fibroblasts and frozen kidney biopsies
from normal and diabetic mice, stained under different
assay conditions. The values derived from this analysis
are termed b-galactosidase activity values (BGAVs) and
are highly sensitive and reproducible.
Results
Image processing of the standard SABG assay
The SABG assay produces blue-green staining in the
cytoplasm of positive cells, albeit there is great variabil-
ity in the degree of staining among the positive cells. In
order to objectively quantify this staining we utilized the
protocol for SABG staining as previously described [16],
and proceeded to capture and digitally analyze images of
the stained cells. This quantification method, based on
color intensity analysis of the photographed images,
generates values of Cell Staining Intensity (CSI) mea-
sured in arbitrary intensity units. CSI values are the pro-
duct of the ratio between the green plus blue values of
each pixel in the manually marked cell cytoplasm and
the total color (red, green and blue) in the same cyto-
plasm, divided by the cell surface area. Standardization
of each single CSI value is achieved by dividing the CSI
value with the adjacent background staining intensity
(BSI) value (Figure 1A, B). We found that the back-
ground is uneven over the photographed area and there-
fore standardization to the figure background is best
achieved by marking a background area adjacent to each
analyzed cell. In order to decrease the signal to noise
ratio, we applied a logarithmic transformation to the
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For each experiment a minimum of 250 cells were ana-
lyzed to generate BGAVs, which were further analyzed
as mean values and distributions.
T oa p p l yt h i sa n a l y s i st op rimary human fibroblasts
aged in culture and in order to determine the preferred
analysis strategy, we stained and calculated CSI/BSI and
BGAVs for two different primary fibroblast cell lines,
FSE and BJ, at various population doublings (PDs). We
applied normality tests for these values, and found
higher normal distribution indices for BGAVs versus
CSI/BSI (Figure 1C). The Shapiro-Wilk W (SWW)
BGAVs of 250 FSE cells at PD 38 was higher than the
CSI/BSI ratio of the same cells, yielding a better fit to a
normal distribution. Nevertheless, in most instances the
BGAVs did not fit a normal distribution according to
either Shapiro-Wilk W or Kolmogorov-Smirnov normal-
ity tests, and therefore in our statistical analysis we used
the Kolmogorov Smirnov test, rather than the Student’s
t-test, which assumes normal distribution.
The first scoring of BGAVs was performed on images
captured 8 hours following the start of the incubation
with the X-Gal staining solution, immediately after stop-
ping the staining reaction by washings with PBS, as
described in “Methods”. In order to examine whether
the BGAVs change as a function of the time elapsed
since the staining was completed, we continued to mea-
sure the mean BGAV of 250 cells at different time
points following staining. We observed a parabolic
behavior of the mean BGAV over time, peaking at
16 hours after the termination of the staining reaction
(Figure 1D). The BGAVs reached a plateau 40 hours
after the staining reaction was terminated and remained
s t a b l ef o ra sl o n ga st w om o n t h s .W eh a v ec h o s e nt h e
values attained at the plateau stage as more reliable and
stable markers for quantifying the degree of SABG stain-
ing and proceeded to acquire all our images at least
40 hours after completion of staining.
BGAVs in Cellular Senescence pathways
The SABG assay was originally introduced to measure
RS [16]. In order to confirm that our quantification ana-
lysis indeed detects this type of senescence, we mea-
sured the mean BGAV in FSE and BJ fibroblasts at
progressively increasing PDs. Our measurements in the
FSE cells demonstrated a steady increase in BGAVs
between PDs 34-58, and in BJ fibroblasts between PDs
57-65 (Figure 2). Analysis of cell surface areas from FSE
cells at PDs 34 to 56 presented a concomitant gradual
increase in the mean cell surface area from 24520 pixels
to 39125 pixels respectively as expected in cells
approaching CS, and this change was statistically signifi-
cant (p < 10
-5). We fully appreciate the fact that accu-
rate cell area can only be calculated using confocal
microscopy, though for the purpose of validating the
quantitative SABG assay we did not consider this to be
necessary. The increase in mean cell surface area would
be expected to yield a lower mean BGAV in cells
Figure 1 Application of a digital image-processing tool to the
standard SABG assay. A. SABG staining of FSE cells (PD 34) at pH
6.0. B. Image analysis of the field shown in Figure 1A using the
Matlab tool described in “Materials”. The cell membrane borders
and the background control area (small circles) were marked
manually. The logarithmic ratio of the cytoplasmic staining intensity
(CSI) divided by the background staining intensity (BSI), yields the
BGAV. C. Shapiro-Wilk W (SWW) normality test applied to the CSI/BSI
values (green line) and to the BGAVs (blue line) obtained from FSE
cells at progressively increasing PDs. For any given PD of the FSE
cells, the SWW normality value of the logarithmic ratio (BGAV) was
higher than the CSI/BSI ratio, indicating a better fit with a normal
distribution when applying logarithmic transformation to the CSI/BSI
ratio. D. BGAV variation over time. Measurement of BGAVs of FSE
cells at different time periods after completion of staining yielded a
parabolic distribution of the BGAVs, peaking at 16 hours, and
reaching a plateau after 48 hours which remains as such for as long
as 2 months following the completion of the staining reaction. This
analysis was carried out for FSE cells at two different PDs: PD 43
(green line) and PD 53 (blue line). Hour (h), month (m).
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f o rC S I .H o w e v e r ,a sd e m o n s t r a t e di nF i g u r e2 ,t h e
increase in the mean BGAV from -12.2 ± 13.7 at PD 34
to 4.3 ± 14.7 at PD 56 (p < 10
-5), validates the efficacy
and reliability of this method to observe and measure
changes in SABG staining associated with RS.
Many studies have shown that SIPS is also associated
with positive SABG staining [12,27]. In order to further
validate the reliability of our method, we exposed FSE
cells at PD 34 to gradually increasing concentrations of
H2O2 in order to induce acute SIPS. Indeed, an H2O2
concentration dependent increase in the mean BGAV
w a so b s e r v e d( F i g u r e3 ) .T h em e a nB G A Vw a ss i g n i f i -
cantly higher after exposure to 15 uM H2O2 (-3.4 ±
17.8) in comparison to no added H2O2 (-12.2 ± 13.7)
(p < 10
-5). No significant differences in BGAVs were
observed between H2O2 concentrations of 15 uM and
20 uM (p = 0.2183). BGAVs reached a plateau at 25 uM
H2O2. Cell death occurred when cells were exposed to
H2O2 concentrations higher than 50 uM such that the
cells could not be analyzed for BGAVs at these concen-
trations. Hence, BGAVs appear useful in documenting
SIPS-induced SABG staining, as well.
The effect of pH on BGAVs
Recent studies have demonstrated that SABG activity at
pH 6.0 in mammalian cells emanates from the activity
of the lysosomal enzyme GLB1 [23]. This pH is subopti-
mal for this enzyme’s activity that normally is carried
out in the highly acidified lysosomes. The optimal pH
for lysosomal b-galactosidase activity in human fibro-
blasts and leukocytes is situated between pH 4.2 - 4.6,
and activity declines by approximately 25% at pH 5.0
and by 50% at pH 5.5 [28]. Apparently, only senescent
cells with high b-galactosidase activity yield detectable
staining at pH 6.0 [23]. Accordingly, it has been the
accepted convention to date to carry out the SABG
assay at pH 6.0, since at pH 4.0 most cells are positively
stained due to basal lysosomal b galactosidase activity
(Figure 4A) and therefore differentiation between levels
of activity was considered not feasible at pH 4.0. How-
ever the b-galactosidase activity measured in late- com-
pared to early-passage fibroblasts was six to seven-fold
higher both at pH 4.5 and pH 6.0 [23]. We therefore
proceeded to study whether our quantification method
m i g h tb ea b l et om e a s u r ed i f f e r e n c e si ns t a i n i n g
Figure 2 BGAVs change with increasing population doublings.
The BGAVs obtained at pH 6.0 at progressively increasing PDs of
both FSE and BJ fibroblast cells. FSE cells were analyzed between
PD 34-58 and BJ cells were analyzed between PD 57-65. Both cell
types were stained for SABG activity at weekly intervals.
Figure 3 H2O2 Stress-Induced Premature Senescence measured
by BGAVs. BGAVs of FSE cells stained at pH 6.0 increased
progressively with exposure to increasing concentrations of H2O2.
Concentrations of H2O2 higher than 50 μM resulted in cell death
such that the cells could not be analyzed for BGAVs.
Figure 4 pH effect on BGAVs. A. FSE cells at PD 34 stained at pH
4.0. All cells demonstrated some degree of staining. B. BGAVs are
inversely related to the pH at which the reaction was carried out.
Staining was performed on FSE cells at PD 42 under different pH
conditions. C. The effect of increasing PDs on BGAVs obtained at pH
4.0. FSE cells at progressively increasing PDs were stained at pH 4.0
and analyzed for BGAVs. D. The effect of H2O2 on BGAVs obtained
at pH 4.0. FSE cells were treated with progressively increasing H2O2
concentrations and BGAVs were determined at each concentration.
Shlush et al. BMC Cell Biology 2011, 12:16
http://www.biomedcentral.com/1471-2121/12/16
Page 4 of 10intensities obtained at pH values other than pH 6.0 in
fibroblasts at early and late PDs. To this end, we first
measured BGAVs obtained at different levels of pH in
FSE cells at PD 39, a stage at which fibroblast cells are
barely stained at pH 6.0. As shown in Figure 4B, the
BGAVs decreased as the pH increased, and the highest
BGAVs were attained when staining was performed at
pH 4.0. Following this finding we analyzed the BGAVs
obtained at pH 4.0 during RS and SIPS. We observed
that both at RS (Figure 4C) and SIPS (Figure 4D) stain-
ing at pH 4.0 increased the resolution between the
BGAVs at low PDs, or at low H2O2 values. While the
mean pH 4.0-BGAV at PD 34 (65.6 ± 45.5), was signifi-
cantly lower than at PD 42 (88.4 ± 60.4) (p = 0.0001)
(Figure 4C), this significant difference could not be
documented at the same PDs with pH 6.0-staining (Fig-
ure 2). Similarly, readily discernible differences were
obtained while comparing the mean BGAV at 15 uM
H2O2 compared with 20 uM H2O2 when staining was
done at pH 4.0, however this was not the case at pH
6.0. Therefore, we conclude that in order to measure
smaller increments in the SABG activity or to perform
this assay more accurately, it is beneficial to perform the
staining procedure also at pH 4.0 due to the increased
sensitivity of the BGAVs at this pH. However this
requires a rigorous quantitative assay for histochemical
staining intensity in order to distinguish the range of
intensity of positive staining.
The effect of cell density on BGAVs
Earlier studies have reported that the degree of SABG
staining is influenced by cell density, such that more
intense staining is obtained when cells are closer to con-
fluence [25]. In order to determine whether confluence
effects are evident using our analytic approach, the
mean BGAV was determined in wells at different con-
fluence levels. ANOVA analysis of the mean BGAV at
pH 4.0 in two duplicate experiments using FSE cells
showed no differences with varying cell density (p =
0.1), even when cells were plated at a high density
(250,000 cells per well) (Figure 5).
In situ SABG assay
The potential roles CS plays in organismal aging and in
tumor suppression raise the importance of a reliable
quantitative method to determine CS in vivo.W eh a v e
chosen to focus in the current study on kidney biopsies,
in which CS has been described in various forms of kid-
ney pathology [29-31]. Specifically, we have focused on
type 2 diabetes mellitus (DM) wherein increased CS,
quantified by SABG and p16INK4a, has been demon-
strated in human subjects [32]. We have used a well-
accepted streptozotocin (STZ) model of murine diabetes
mellitus [33] in order to analyze SABG activity in renal
tubules 7, 9 and 13 weeks following the administration
of STZ. At pH 6.0 no positively stained kidney cells
were detected and analysis by our software indicated
that the mean BGAV was not statistically different
between diabetics and controls at all 3 time points
(Figure 6B). We hypothesized that b-galactosidase activ-
ity in mouse kidney cells may be low and detectable
only at the optimal pH, and therefore applied the SABG
a s s a ya l s oa tp H4 . 0 .I n d e e d ,t h eB G A V sm e a s u r e di n
tubular cells at pH 4.0 differed significantly between the
kidney samples of the diabetic mouse and the controls
at all three time points (7 weeks p < 0.004; 9 weeks p <
0.0009; 13 weeks p < 10E
-8) (Figure 6A). The staining
was specific to tubular cells and no positive staining was
detected in the glomeruli or interstitial tissue from both
diabetic and control mice. In addition, the analysis
revealed that the BGAVs at pH 4.0 increased gradually
in both diabetics and controls between week 7 and week
13 (p = 5E
-6,6 E
-6 respectively) reflecting changes in
SABG activity most likely due to aging.
In order to verify that the SABG staining indeed
detects senescent cells in the kidney, we proceeded to
analyze the kidney samples for an additional marker of
senescence. We performed immunofluorescent (IF)
staining with an antibody for g-H2AX, a quantitative
indicator of senescence both in vivo and in vitro [34].
One hundred nuclei in tubular cells of both diabetic and
control mice at the 13-week time point were scored for
the number of foci present in the nucleus (Figure 7).
The number of nuclei containing one or more g-H2AX
foci was significantly higher in the tissue originating
from the diabetic mouse in comparison to the control
mouse (Pearson’s chi-square = 44.9, p = 2.1E
-11). More-
over, by comparing the percentage of g-H2AX-positive
nuclei with pH 4-SABG-positive tubules (defined as
Figure 5 Cell Density and BGAVs.F S Ec e l l sa tP D s4 2a n d4 6
were plated at increasing densities (20,000 -250,000 cells/well) and
stained at pH 4.0. BGAVs were determined at the different cell
densities.
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score for the corresponding control tubules), the corre-
lation coefficient was calculated to be 0.96, providing
further reassurance that indeed the SABG staining at
pH 4.0 identifies senescent cells.
Discussion
Cellular senescence is a final common pathway for a
number of DDR pathways, and appears to play a major
role in normal aging, acute stress conditions, and possi-
bly as a tumor suppressor mechanism [5,14]. Despite its
wide relevance to both normal tissue kinetics, and orga-
nismal aging, CS lacks definitive well-characterized and
easily measured biomarkers. Senescence-associated b-
galactosidase staining has been the most widely used
technique to characterize senescent cells, however sev-
eral recent studies highlight a number of caveats using
this assay [25,26,35]. A major limitation of the SABG
assay is the subjective assignment of cells as being posi-
tively or negatively stained. As a result, new quantitative
SABG assays have been developed. These methods
include measurement in cell extracts of the conversion
rate of 4-methylumbelliferyl-D-galactopyranoside
(MUG) to the fluorescent hydrolysis product 4-methy-
lumbelliferone (4-MU) [36] and a method based on the
levels of fluorescein di-(b)-D-galactopyranoside in the
Figure 6 In situ kidney SABG activity in diabetic and non-diabetic mice. SABG staining was carried out for kidney sections, and renal
tubule-BGAVs were measured for both control and diabetic (DM) mice at 3 time points (7, 9 and 13 weeks) at pH 4.0 (A) or pH 6.0 (B). DM
mice were analyzed by two independent experiments at the 9- and 13-week time points for each pH. Cross-sections are from kidneys at the 13-
week time point, for both control and diabetic mice. A. At all three time points SABG staining was apparent and BGAVs for the diabetic mouse
was significantly higher than those for the control mouse (7 weeks p < 0.004; 9 weeks p < 0.0009; 13 weeks p < 10E
-8). Values at the 9- and 13-
week time points for the DM mice represent the mean of two independent experiments (SD = 35.9 and 27, respectively). A black line in both
tissue samples demarcates a positively stained tubule. B. No SABG staining was apparent at pH 6.0 for control and diabetic mice and renal
tubule-BGAVs were not significantly different between the groups. Values at the 9- and 13- week time points for DM mice represent the mean
of two independent experiments (SD = 4.6 and 18.6, respectively). A black line in both tissue samples demarcates a negatively stained tubule.
Figure 7 g-H2AX foci in diabetic and non-diabetic mice. g-H2AX
staining was carried out for kidney sections at the 13-week time
point for both control and diabetic (DM) mice. Red - g-H2AX signals,
Blue - DAPI nuclear staining. One hundred tubule cells from each
sample were analyzed for the number of g-H2AX foci present in the
nucleus. The percentage of cells displaying 0-3 foci per nucleus
appears in the graph (3 foci was the maximum number of foci
detected per nucleus).
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assay has also been recently reported [38], as well as
FACS staining of SABG [39]. All these methods have
yielded promising results for a quantitative measure of
SABG, but are not designed for in situ quantification of
SABG activity. We have used the platform of the origi-
nal SABG assay [16] as the basis for developing an in
situ reproducible quantitative assay. The digital image-
analysis we describe herein enables the quantification of
SABG staining in uniform units, and distinguishes dif-
ferent degrees of staining. In addition, our analysis sug-
gests that SABG staining is not influenced by cell
density up to a certain degree of confluence in either
pre-senescent or senescent cells (Figure 5).
A further modification and validation of this assay is
varying the pH at which the assay is carried out to
include pH 4.0, at which biochemical activity of the
GLB1 product is significantly higher [23]. The original
description of SABG assay at pH 6.0 was meant to gen-
erate a threshold at which only cells with senescence-
dependent accumulation of the enzyme (now known to
be the GLB1 gene product) and consequently higher
activity stain positively. Qualitative SABG assay at a
higher pH might be simpler and faster for interpretation
when striking qualitative differences are being assessed.
However, staining at pH 4.0 renders the assay more sen-
sitive to subtle changes, such as occur under conditions
of metabolic stress, as demonstrated by the intensity of
the staining after treatment with hydrogen peroxide.
SABG staining at pH 4.0 also enabled identification of
CS in kidney samples of diabetic mice that was not evi-
dent at pH 6.0. While pH 4.0-4.5 is the optimal pH for
SABG activity, [36,40], without the digital analysis, sub-
jective scoring will lose its utility for determination of
CS as most cells will seem to be positively stained.
Thus, in conclusion the pH of the assay should be
adjusted in accordance with the biological question.
An evident advantage of a histochemical assay over a
fluorimetric approach, as described by Yang and Hu
[37], is the capacity for in situ quantification to shed
light on CS at the level of individual cells and not only
at the level of a whole cell population. Furthermore, the
main innovation in our method is the ability to quantify
in situ mixed cellular tissue sections and evaluate the
SABG activity in specific cell types. Since many tissues
are constituted of various types of cells, only the in situ
staining can provide insights into the type of cells in a
mixed population demonstrating high SABG activity.
As noted above, in situ visualization of SABG in dia-
betic mouse kidneys was possible only when the SABG
assay was performed at pH 4.0.P r e v i o u sS A B Ga c t i v i t y
studies on in situ samples [16] have shown a qualitative
increase in SABG activity in tissues from elderly patients
even at pH 6.0. However no such staining was evident at
pH 6.0 in the kidneys of the diabetic mice in the current
study. Other studies in which SABG assay was used as a
marker for CS in tissues have also frequently yielded
conflicting results [25], and it has been suggested that
activity is not causally related to CS induction [23]. In
this study we have confirmed by an independent assay
that indeed the kidneys of the diabetic mice harbor
senescent cells. Herein we suggest that the ambiguity
related to the SABG staining as a CS marker in tissues
might have been the result of measurement of SABG
activity at a high and suboptimal pH. However, once
again we emphasize that extending the assay to the
more sensitive pH of 4.0 must be coupled with quantifi-
cation of staining to achieve interpretable results.
Conclusions
Utilization of an objective quantitative measurement of
SABG activity by digital image analysis has proved to be
accurate and reproducible in detecting cellular senes-
cence derived by several stimuli. The increased SABG
activity observed among in situ tissue sections from dia-
betic mouse kidneys was observed only when the assay
was performed at a physiologic pH 4.0, and the analysis
was enabled due to the use of computer aided image
analysis. A major advantage and novelty of this
approach in comparison to other qualitative and quanti-
tative SABG methods is the ability to analyze tissue sec-
tions in the study of in situ senescence.
Methods
Cell culture conditions
Human primary foreskin fibroblasts (FSE) [41] and BJ
[42] (obtained from Woodring Wright, University of
Texas, Southwestern Medical Center, TX, USA) were
cultured and brought to replicative senescence as
described previously [41].
H202 treatment of cells
FSE cells were exposed to H2O2, diluted in PBS, at dif-
ferent concentrations (0-100 μM). Following incubation
with H2O2 cells were washed with PBS and grown for
an additional 48 hours in culture medium prior to stain-
ing. Control cultures at the same population doubling
followed the same schedule of medium changes without
exposure to exogenous H2O2.
Senescence associated b-galactosidase assay
Cells were seeded 48 hours prior to staining at 2-4 ×
10
4 cells/well in six well plates. This cell density ensures
that the staining is performed before the cultures reach
confluence. SA-b-Gal staining was performed as pre-
viously described with minor modifications [16]. Briefly,
the cells were washed with cold PBS, and fixed for 5
min with 0.5% glutaraldehyde diluted in cold PBS. After
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hours at 37°C in staining solution containing 1 mg/ml
5-bromo-4-chloro-3-indolyl-b-D-galactoside (X-Gal)
(Roche) and the rest of the components described in
[16]. For staining at different pH values, 0.1 M citric
acid and 0.2 M Na2HPO4 solutions were mixed at
a p p r o p r i a t ep r o p o r t i o n s .F o rp H4 . 0-3 8 . 6m lo f0 . 2M
Na2HPO4 were mixed with 61.5 ml of 0.1 M citric acid,
and for pH 6.0 - 63.2 ml of 0.2 M Na2HPO4 were
mixed with 36.9 ml of 0.1 M citric acid. Following the
incubation period at 37°C, cells were washed 3 × 5 min-
utes with cold PBS and stored in PBS at 4°C until
images were collected.
For analysis of the effect of cell density on SABG
activity, FSE cells from two different PDs (42 and 46)
were seeded at increasing densities ranging from 20 ×
10
3/well to 250 × 10
3/well (in 6-well plates), and cul-
tured until the well containing the highest cell density
reached confluence.
Diabetic animal model
Two-month-old C57Bl/6 mice were injected intra-peri-
toneal for 5 consecutive days with the pancreatic islet b
cell toxin, STZ, at a concentration of 50 mg/kg dissolved
in 50 mM citrate buffer pH 4.5. Blood glucose levels
were monitored once a week with DM being defined as
a consistent blood glucose level higher than 200 mg/dl.
Mice were sacrificed at 3 time points (7 weeks after
injection, 9 weeks after injection and 13 weeks after
injection). The experiment was repeated twice for the 9-
and 13-week time points. Anesthesia was carried out by
injection of a mixture of ketamine and xylazine. Kidneys
were removed and embedded in optimal cutting tem-
perature compound (Tissue-Tek, Sakura), snap-frozen in
liquid nitrogen-cooled methylbutane and stored at -70°
C. The institutional animal care and welfare committee
approved these experimental protocols.
In-Situ SABG staining
Frozen kidney sections were cut at 6 μma n dk e p to n
dry ice until further processed. Slides were fixed with
2% formaldehyde/0.2% glutaraldehyde in PBS for 5 min-
utes. After washing with ice cold PBS, slides were incu-
bated over night at 37°C with SA-b-Gal staining
solution previously described [16]. Following staining,
slides were incubated for 48 h in ice cold PBS, and then
were counterstained with eosin, dehydrated, and
mounted as described [16].
Microscopy, image analysis and BGAV analysis
Analysis of tissue-culture cells
Color images of SABG stained tissue culture cells were
captured on a Nikon eclipse TS100 inverted microscope
using a 10× objective and a Nikon Coolpix E995 digital
camera 40-48 hours post staining. In several cases, spe-
cific wells were photographed several times at different
intervals after staining was completed (8 hours to 2
months) to determine whether BGAVs change over
time.
Quantitative analysis of the images was performed
using a Matlab application for cell marking (Segment-
Gui) and color analysis (detailed instructions and down-
load appear on website http://md.technion.ac.il/pictures/
storage/45/47.zip). A minimum of 250 randomly chosen
cells was marked manually for each measurement point.
Analysis of stained tissues
The images of stained tissues were captured on a BX51
Olympus microscope using a 20× objective with an
Olympus DP70 digital camera controlled by analySIS
software (Soft Imaging System). Image acquisition was
performed with the following fixed color settings: red =
0.36, green = 0.92, blue = 0.85, offset = 504, and expo-
sure time of 6.8 ms.
Analysis of BGAVs was performed on whole renal
tubules (Figure 6). At least 50 tubules were analyzed
from each mouse (DM and control) at each of the 3
time points. Experiments were carried out in duplicates
for the DM mice at the 9- and 13-week time points.
Statistical Analysis
The distributions of SABG values were compared to a
normal distribution by the use of Shapiro Wilk W nor-
mality test. Since most distributions deviated signifi-
cantly from a normal distribution (see “Results”), we
used the two sample Kolmogorov Smirnov test to calcu-
late distribution differences between the different cell
samples and for calculation of the p values.
Immunofluorescence analysis of g-H2AX foci
The staining of the mouse kidney tissue with antibodies
for g-H2AX was carried out as described previously [2].
Briefly, 8 μM sections were cut from the frozen kidney
biopsies and immediately fixed for 20 minutes in freshly
prepared 4% paraformaldehyde diluted in PBS. Follow-
ing the fixation, the tissue sections were permeabilized
for 20 minutes with PBST (PBS + 0.2% Triton X100).
Sections were blocked for 1 hour in blocking solution
consisting of PBS + 4% BSA at room temperature (RT)
and incubated over night at 4°C with anti-g-H2AX
(S139, Upstate; Chicago, IL) diluted 1:750 in blocking
solution. The following day, the slides were washed 3 ×
5 minutes in PBST at RT, and incubated with a second-
ary antibody (Cy3- conjugated donkey anti-rabbit anti-
body) for 1 hour at RT, Slides were then washed 3 × 5
minutes in PBST at RT and mounted with Vectashield
containing DAPI (H-1200, VECTOR LABORATORIES).
Fluorescence signals in stained tissue were analyzed
using laser scanning confocal microscopy (LSM 510
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Page 8 of 10Meta Confocal, Carl Zeiss Inc. Germany). Nuclei were
scored for the number of g-H2AX foci present in each
nucleus. Differences in number of foci between diabetic
and control tissues were compared by Pearson’sc h i -
square test.
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